Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

BACKGROUND. Glioblastoma (GBM) is the most common primary malignant brain tumor and has a dismal prognosis. Measles virus (MV) therapy of GBM is a promising strategy due to preclinical efficacy, excellent clinical safety, and its ability to evoke antitumor pro-inflammatory responses. We hypothesized...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Hardcastle, Jayson, Mills, Lisa, Malo, Courtney S., Jin, Fang, Kurokawa, Cheyne, Geekiyanage, Hirosha, Schroeder, Mark, Sarkaria, Jann, Johnson, Aaron J., Galanis, Evanthia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464320/
https://ncbi.nlm.nih.gov/pubmed/27663389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now179
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller